Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same
US12012454B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2022 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Mar 11, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70539
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides an anti-tumor antigen nanobody that specifically binds to a human leukocyte antigen-G. The present disclosure also provides the nucleic acid sequence of the anti-tumor antigen nanobody, use of the anti-tumor antigen nanobody for treating cancer and immune-related disorders, and a method for detecting expression levels of HLA-G.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.